Switzerland· 68338001

Hepcludex

A bulevirtide product containing bulevirtidum, registered in Switzerland and dispensed under Swissmedic category A, on the national reimbursement list. The same ATC class is registered in 14 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat A (Swissmedic)ATC J05AX28

Checked against BAG Spezialitätenliste (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHBAG Spezialitätenliste (Switzerland)normalisedHepcludexATCJ05AX28REGISTER NO.68338001PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Bulevirtide is registered in 14 of 19 countries.

Countries holding a registration under ATC J05AX28 (bulevirtide), each read from that country’s own register.

  • This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
  • 10 of them publish a price we can compare per daily dose

Bulevirtide · ATC J05AX28

14 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of bulevirtide costs, country by country.

Normalised to the WHO defined daily dose (2 mg), so markets compare like for like.

  • Switzerland: $219.16 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Bulevirtide · price per daily dose (2 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$219.16
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

BAG Spezialitätenliste (Switzerland)
Active substance
bulevirtidum
Manufacturer
—
Country
Switzerland (CH)
ATC code
J05AX28
ATC class
Bulevirtide
Defined daily dose
2 mg, P
Swissmedic category
A
Reimbursed
Yes
Source register
BAG Spezialitätenliste (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680683380014
    Durchstf 30 Stk
    CHF 5452.65

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ecce7cc6-1323-46c9-a4c2-dc3dcc3fb1bb
GET /v1/drugs/ecce7cc6-1323-46c9-a4c2-dc3dcc3fb1bb?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "bulevirtidum 2 mg",
  "valid_from": "2025-02-01",
  "limitations": "[{\"description\":\"HEPCLUDEX wird nur nach Kostengutsprache durch den Krankenversicherer nach vorgängiger Konsultation des Vertrauensarztes vergütet.<br>\\nHEPCLUDEX wird vergütet zur Behandlung einer chronischen Hepatitis-Delta-Virus (HDV)-Infektion bei erwachsenen Patienten mit kompensierter Lebererkrankung.<br> \\nDie Verschreibung kann nur durch Fachärzte der Gastroenterologie mit Schwerpunkt Hepatologie oder Fachärzte der Infektiologie erfolgen.<br>\\n<br>\\nHEPCLUDEX wird nur unter folgenden Voraussetzungen vergütet:<br>\\n• In einer Dosierung von maximal 2 mg / Tag<br>\\n• Als HDV-Monotherapie<br>\\n• Nur in Kombination mit einer Therapie der zugrundeliegenden HBV-Infektion<br>\\n<br>\\n\\n\",\"costApproval\":null,\"indication\":\"21730.01\",\"isNew\":false,\"limitationCode\":null,\"points\":null,\"priceModel\":null,\"title\":null,\"validFrom\":\"2025-02-01\",\"validTo\":\"2027-07-31\"}]",
  "galenic_form": "Trockensub 2 mg",
  "therapeutic_area": null,
  "sl_inclusion_date": "2025-02-01",
  "self_retention_pct": 10
}

See everything about bulevirtide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.